Incomplete data stalls Swiss authorisation of Covid-19 vaccines
Switzerland’s medical regulator Swissmedic says it lacks the necessary information to sign off on three different coronavirus vaccines ordered by the government.
This content was published on
1 minute
Keystone-SDA/ac
Português
pt
Falta de dados atrasa autorização suíça das vacinas Covid-19
The regulator said important data on safety, efficacy and quality are still missing. It has reached out to the manufacturers, who provided data from their studies.
“We lack data on the effectiveness of the clinical trials and on the important subgroups that participated in these large studies,” said Claus Bolte, head of the authorisation division at Swissmedic, at a press briefing on Tuesday organised by the Federal Office of Public Health.
For example, Swissmedic wants to know about the pre-existing illnesses of the people who took part in these studies. According to the regulator, acceptance of such rapidly developed vaccines requires a high degree of trust in manufacturers and approving authorities. It is therefore important to examine very closely the effects on different groups of people.
Rollout plan
The government has already placed orders for several million shots of vaccine from three manufacturers: Pfizer/BioNTech, AstraZeneca, and Moderna.
At the press conference, authorities said vaccines will be offered free of charge and priority will be given to the most vulnerable groups and health workers. The services of the army will be enlisted to ensure stockage and distribution and the country’s 26 cantons will be in charge of setting up vaccination centres.
Protein in abdominal fat could help shape obesity treatment
This content was published on
The study analysed fat cells from different locations in the body, and found that those in the abdomen have unique properties.
North African asylum claims fall after rapid Swiss processing
This content was published on
The accelerated procedure, now out of its test phase, has resulted in a significant drop in applications from North African countries.
This content was published on
The artist's song "The Code" focuses on their journey as a nonbinary individual. It is one of the favourites to win this year's contest.
Swiss climate activists block vehicles near Gotthard tunnel
This content was published on
Around ten climate activists briefly blocked the A2 motorway near the northern entrance of the Gotthard tunnel on Thursday.
Watches belonging to Michael Schumacher up for auction
This content was published on
Schumacher's family is auctioning off eight rare watches from his collection in Geneva. The Christie's auction will take place on Monday.
Joya Marleen and Baschi named best solo acts at Swiss Music Awards
This content was published on
St. Gallen singer Joya Marleen and Baschi from Basel were named artists of the year at the Swiss Music Awards 2024 on Wednesday night.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Can Switzerland convince its people to take the Covid-19 vaccine?
This content was published on
With several vaccines in late stages of development, the next step is to address widespread scepticism so enough people will agree to the jab.
Swiss stump up more cash to buy a Covid-19 vaccine
This content was published on
Interior Minister Alain Berset, who announced the news on Wednesday, said the aim was to provide a “safe and efficient product of high-quality” for the population in Switzerland. The allocation of funds comes on top of CHF300 million approved earlier this year. So far, Switzerland has assured reservations for about 13 million doses of prospective…
Why Switzerland’s Moderna Covid-19 vaccine deal is risky
This content was published on
Switzerland’s vaccine order – its first such move – is a sign that it holds little hope for fair distribution of a Covid-19 shot.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.